Clarivate Plc Intrinsic Value – Clarivate Reveals 22 Exceptional Scientists and Economists Named 2024 Citation Laureates
September 26, 2024

🌥️Trending News
Clarivate ($NYSE:CLVT) PLC is a global information and analytics company that specializes in providing insights and solutions to accelerate the pace of innovation. The company offers a wide range of data and tools to help organizations, universities, and governments make informed decisions and drive research and development. Recently, Clarivate announced its selection of 22 outstanding scientists and economists as the 2024 Citation Laureates. These individuals have been recognized for their remarkable achievements and contributions to their respective fields, which include medicine, chemistry, physics, and economics. The 2024 Citation Laureates come from six different countries, including the United States, United Kingdom, Canada, Japan, Israel, and France. They have been chosen for their groundbreaking research and discoveries that have significantly impacted their fields and have the potential to shape the future of science and economics.
Clarivate’s selection of these exceptional individuals serves as a testament to the company’s commitment to recognizing and honoring the achievements of researchers around the world. By highlighting the work of these Citation Laureates, Clarivate hopes to inspire future generations of scientists and economists to push the boundaries of knowledge and drive innovation. These researchers represent the top 1% in their respective fields and have been cited the most by their peers in the past decade. Both the Citation Laureates and Highly Cited Researchers lists are based on analysis from Clarivate’s Web of Science database, which is considered the gold standard for research citation data. These individuals have not only made significant contributions to their fields but also have the potential to shape the future of science and economics.
Market Price
This prestigious honor recognizes individuals who have made significant contributions to their respective fields, as demonstrated by the high number of citations their publications have received. The Citation Laureates are often seen as potential recipients of the Nobel Prize, as many past Laureates have gone on to receive this esteemed award. The announcement of the 2024 Citation Laureates was accompanied by a slight dip in Clarivate PLC‘s stock price. The stock opened at $6.8 and closed at $6.68, down by 2.2% from the previous closing price of $6.83.
However, this dip is likely due to broader market trends and does not reflect any negative impact on the company’s financials or operations. This year’s Citation Laureates span a diverse range of fields, including chemistry, physics, medicine, and economics. Among them are renowned names such as microbiologist Bonnie Bassler, economist Raj Chetty, and physicist Christopher Monroe. These individuals have made groundbreaking discoveries and advancements in their fields, shaping our understanding of the world and driving progress in areas such as healthcare and technology. It is worth noting that Clarivate PLC is the sole provider of the citation data used to determine the Citation Laureate recipients. The company’s Web of Science database tracks and indexes research publications from around the world, making it an essential tool for researchers, institutions, and governments. The fact that Clarivate PLC’s data is trusted and relied upon by top organizations to identify leading researchers speaks to the company’s reputation for accuracy and reliability. Overall, Clarivate PLC’s announcement of the 2024 Citation Laureates highlights both the company’s role in promoting global research and innovation and the exceptional achievements of the honorees. As we look towards 2024, we can expect to see these Laureates continuing to make significant contributions to their fields and inspiring future generations of scientists and economists. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Clarivate Plc. More…
| Total Revenues | Net Income | Net Margin |
| 2.63k | -986.6 | -0.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Clarivate Plc. More…
| Operations | Investing | Financing |
| 744.2 | -237.4 | -496.5 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Clarivate Plc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 12.71k | 6.71k | 9 |
Key Ratios Snapshot
Some of the financial key ratios for Clarivate Plc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 28.0% | 379.7% | -27.3% |
| FCF Margin | ROE | ROA |
| 19.1% | -7.1% | -3.5% |
Analysis – Clarivate Plc Intrinsic Value
As an investment analysis company, GoodWhale has conducted thorough assessments of the wellness of CLARIVATE PLC. Through our analysis, we have determined that the intrinsic value of a share of CLARIVATE PLC stock is approximately $18.1. This value was calculated using our proprietary Valuation Line, which takes into account various financial indicators such as revenue, earnings, and growth potential. Currently, the stock of CLARIVATE PLC is trading at $6.68, which indicates that it is undervalued by 63.1%. This means that the market price of the stock is significantly lower than its intrinsic value, making it a potentially attractive investment opportunity. Our assessment also takes into consideration the overall wellness of CLARIVATE PLC as a company. We have analyzed their financial statements, market trends, and competitive landscape to determine their current and future prospects. Based on our findings, we believe that CLARIVATE PLC is in a strong position for growth and has the potential to deliver value to its shareholders. In conclusion, our analysis shows that CLARIVATE PLC is currently undervalued and has the potential for significant growth in the future. As always, we recommend conducting further research and consulting with a financial advisor before making any investment decisions. More…

Peers
The competitive landscape in the global market for research and development (R&D) analytics is expected to heat up in the coming years. This is due to the recent acquisition of Thomson Reuters Corporation’s IP & Science business by Clarivate PLC. The move is expected to give Clarivate a significant edge over its competitors, Atos SE, Coforge Ltd, Also Holding AG, in the global market for research and development (R&D) analytics.
– Atos SE ($OTCPK:AEXAY)
Atos SE is a French multinational information technology services company with headquarters in Bezons and offices in France, Spain, and India. It is one of the largest IT services companies in the world with a market cap of 972.75M as of 2022. The company has a Return on Equity of -44.22%.
Atos provides a full range of services including consulting, systems integration, managed services, and cloud operations. The company works with clients in a variety of industries including healthcare, government, financial services, and manufacturing.
– Coforge Ltd ($BSE:532541)
Coforge Ltd is an Indian multinational corporation that provides Information Technology services, including digital, technology, consulting, and operations services. It is headquartered in Pune, India. As of March 2021, the company had a market capitalization of ₹17.29 trillion (US$233.97 billion) and an annual revenue of ₹1.39 trillion (US$19.1 billion). It is one of the Big Four tech companies in India along with Tata Consultancy Services (TCS), Infosys, and Wipro. As of 2020, Coforge is the sixth-largest IT services company in the world by revenue. The company has over 190,000 employees across 42 countries.
Coforge’s market cap and ROE are both very impressive, especially considering the company’s size. The company has a long history and a large customer base, which gives it a competitive advantage in the market. Coforge is a well-diversified company, with a strong presence in both developed and emerging markets. The company has a strong focus on innovation and has been investing heavily in research and development. This has helped Coforge to maintain its leading position in the IT services industry.
– Also Holding AG ($LTS:0QLW)
Given that the company has a market cap of 1.93B as of 2022, a return on equity of 14.87%, and is involved in the production of packaging materials and containers, it would appear that it is a well-established and successful company. The company’s market cap and ROE are both impressive, and its involvement in the production of packaging materials and containers suggests that it has a strong and diversified product offering. The company appears to be well-positioned for continued success in the future.
Summary
Clarivate has recently released its list of 2024 Citation Laureates, which includes 22 scientists and economists from six different countries. This announcement highlights the company’s strong focus on scientific and economic research and expertise. As an investor, this can be seen as a positive sign for the company’s future growth potential.
Additionally, Clarivate’s reputation as a leading provider of analytics and insights for scientific and academic research could attract more clients and investors. The company’s track record of recognizing and honoring exceptional individuals in their fields also reflects positively on its commitment to innovation and excellence. Overall, this news could be a promising factor for potential investors to consider when analyzing Clarivate as a potential investment opportunity.
Recent Posts









